FQI 1
CAS No. 599151-35-6
FQI 1( —— )
Catalog No. M34886 CAS No. 599151-35-6
FQI 1 is a selective late-stage SV40 factor (LSF) inhibitor with anticancer activity that exerts its antiproliferative activity by disrupting the mitotic spindle.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 150 | In Stock |
|
| 50MG | 239 | In Stock |
|
| 100MG | 347 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFQI 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionFQI 1 is a selective late-stage SV40 factor (LSF) inhibitor with anticancer activity that exerts its antiproliferative activity by disrupting the mitotic spindle.
-
DescriptionFQI1 is a Late SV40 Factor (LSF) inhibitor. FQI1 inhibits cell proliferation, with IC50s of 3, 0.79, 6.3 μM for NIH/3T3, HeLa, A549 cells. FQI1 can be used for cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number599151-35-6
-
Formula Weight311.33
-
Molecular FormulaC18H17NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (321.20 mM; Ultrasonic )
-
SMILESCCOc1ccccc1C1CC(=O)Nc2cc3OCOc3cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ulla Hansen, et al. Inhibitors of late sv40 factor (lsf) as cancer chemotherapeutics. WO2012050985.
molnova catalog
related products
-
Adipic acid
From an industrial perspective, it is the most important dicarboxylic acid, mainly as a precursor for the production of nylon.
-
coreopsin
Coreopsin is one of the main components from Coreopsis tinctoria Nutt. Flower(CTF). CTF has been used traditionally in China for treating hypertension and diabetes as well as reducing body weight and blood fat.
-
Rilematovir
JNJ-678 is a novel inhibitor of the fusion protein. JNJ-678 shows the potential for respiratory syncytial virus (RSV) treatment.
Cart
sales@molnova.com